
FMC Corporation FMC
$ 16.05
4.32%
Quarterly report 2025-Q2
added 07-31-2025
FMC Corporation General and Administrative Expenses 2011-2026 | FMC
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses FMC Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 645 M | 734 M | 775 M | 714 M | 730 M | 793 M | 851 M | 619 M | 530 M | 738 M | 621 M | 516 M | 527 M | 442 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 851 M | 442 M | 660 M |
Quarterly General and Administrative Expenses FMC Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 177 M | 172 M | 159 M | 165 M | 164 M | 171 M | 206 M | 186 M | - | 179 M | 195 M | 188 M | - | 184 M | 161 M | 174 M | - | 188 M | 171 M | 189 M | - | 188 M | 197 M | 184 M | - | 195 M | 200 M | 192 M | - | 154 M | 130 M | 114 M | - | 99.9 M | 111 M | 110 M | - | 137 M | 156 M | 298 M | - | 141 M | 120 M | 115 M | - | 125 M | 127 M | 122 M | - | 119 M | 128 M | 129 M | - | 111 M | 109 M | 106 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 298 M | 99.9 M | 158 M |
General and Administrative Expenses of other stocks in the Agricultural inputs industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Акрон
AKRN
|
32.1 B | - | - | - | ||
|
China Green Agriculture
CGA
|
24.4 M | - | 0.51 % | $ 27.6 M | ||
|
Bioceres Crop Solutions Corp.
BIOX
|
47.6 M | $ 0.59 | 2.89 % | $ 435 M | ||
|
ФосАгро
PHOR
|
6.93 B | - | - | - | ||
|
CF Industries Holdings
CF
|
320 M | $ 96.43 | 1.54 % | $ 17.4 B | ||
|
ICL Group Ltd
ICL
|
276 M | $ 5.7 | 1.61 % | $ 7.83 B | ||
|
Nutrien Ltd.
NTR
|
477 M | $ 71.11 | 1.5 % | $ 34.8 B | ||
|
Intrepid Potash
IPI
|
33 M | $ 34.35 | -0.55 % | $ 442 M | ||
|
Corteva
CTVA
|
3.2 B | $ 74.31 | 0.95 % | $ 51.5 B | ||
|
Marrone Bio Innovations
MBII
|
30.6 M | - | -5.9 % | $ 180 M | ||
|
Origin Agritech Limited
SEED
|
73.3 M | $ 1.16 | 5.45 % | $ 6.52 M | ||
|
The Mosaic Company
MOS
|
497 M | $ 30.17 | 2.12 % | $ 9.65 B | ||
|
American Vanguard Corporation
AVD
|
120 M | $ 4.99 | 1.01 % | $ 140 M | ||
|
The Scotts Miracle-Gro Company
SMG
|
603 M | $ 67.37 | 1.11 % | $ 3.88 B | ||
|
Arcadia Biosciences
RKDA
|
14.5 M | $ 1.87 | 2.75 % | $ 2.31 M | ||
|
CVR Partners, LP
UAN
|
28.4 M | $ 109.52 | 1.41 % | $ 1.16 B | ||
|
Yield10 Bioscience
YTEN
|
6.15 M | - | 15.32 % | $ 46.6 M |